Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
Clinical trial NCT06553352 · RECRUITING
Trial details
- NCT number
- NCT06553352
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2026-04-20
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.